These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23885694)

  • 21. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
    Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
    Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population.
    Johnstone EB; Davis G; Zane LT; Cedars MI; Huddleston HG
    Gynecol Endocrinol; 2012 Oct; 28(10):819-22. PubMed ID: 22475130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome.
    Costa EC; Sá JC; Soares EM; Lemos TM; Maranhão TM; Azevedo GD
    Gynecol Endocrinol; 2012 Jan; 28(1):12-5. PubMed ID: 21958393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.
    Indhavivadhana S; Wongwananuruk T; Rattanachaiyanont M; Techatraisak K; Leerasiri P; Tanmahasamut P; Popijan M
    J Med Assoc Thai; 2010 Jun; 93(6):653-60. PubMed ID: 20572369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome in young Czech women with polycystic ovary syndrome.
    Vrbíková J; Vondra K; Cibula D; Dvoráková K; Stanická S; Srámková D; Sindelka G; Hill M; Bendlová B; Skrha J
    Hum Reprod; 2005 Dec; 20(12):3328-32. PubMed ID: 16085666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome.
    Gateva AT; Kamenov ZA
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):161-6. PubMed ID: 22727921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.
    Rahmanpour H; Jamal L; Mousavinasab SN; Esmailzadeh A; Azarkhish K
    J Pediatr Adolesc Gynecol; 2012 Jun; 25(3):208-12. PubMed ID: 22578482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lack of association between idiopathic hirsutism and metabolic disturbances: Iranian PCOS Prevalence Study.
    Sadat Hosseini M; Ramezani Tehrani F; Azizi F
    Gynecol Endocrinol; 2013 Sep; 29(9):821-5. PubMed ID: 23782000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening women with polycystic ovary syndrome for metabolic syndrome.
    Dokras A; Bochner M; Hollinrake E; Markham S; Vanvoorhis B; Jagasia DH
    Obstet Gynecol; 2005 Jul; 106(1):131-7. PubMed ID: 15994628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
    Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N
    Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'.
    Bhattacharya SM; Jha A
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1303-7. PubMed ID: 21535308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Katsikis I
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.